324 related articles for article (PubMed ID: 22706011)
1. The design and evaluation of HIV-1 vaccines.
Saunders KO; Rudicell RS; Nabel GJ
AIDS; 2012 Jun; 26(10):1293-302. PubMed ID: 22706011
[TBL] [Abstract][Full Text] [Related]
2. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
3. No acquisition: a new ambition for HIV vaccine development?
Lakhashe SK; Silvestri G; Ruprecht RM
Curr Opin Virol; 2011 Oct; 1(4):246-53. PubMed ID: 22081778
[TBL] [Abstract][Full Text] [Related]
4. The HIV vaccine pipeline, from preclinical to phase III.
Schultz AM; Bradac JA
AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163
[No Abstract] [Full Text] [Related]
5. Human immunodeficiency virus vaccines.
Goepfert P; Bansal A
Infect Dis Clin North Am; 2014 Dec; 28(4):615-31. PubMed ID: 25287587
[TBL] [Abstract][Full Text] [Related]
6. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.
Kwong PD; Mascola JR; Nabel GJ
Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a007278. PubMed ID: 22229123
[TBL] [Abstract][Full Text] [Related]
7. Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.
Rolland M; Gilbert P
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):400-4. PubMed ID: 21902593
[TBL] [Abstract][Full Text] [Related]
8. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
9. HIV vaccines: progress to date.
Munier CM; Andersen CR; Kelleher AD
Drugs; 2011 Mar; 71(4):387-414. PubMed ID: 21395355
[TBL] [Abstract][Full Text] [Related]
10. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning.
Kwong PD; Mascola JR; Nabel GJ
Nat Rev Immunol; 2013 Sep; 13(9):693-701. PubMed ID: 23969737
[TBL] [Abstract][Full Text] [Related]
11. What hope is there for an HIV vaccine?
Witten G
S Afr Med J; 2004 Oct; 94(10):831. PubMed ID: 15532757
[No Abstract] [Full Text] [Related]
12. HIV-1 vaccines and adaptive trial designs.
Corey L; Nabel GJ; Dieffenbach C; Gilbert P; Haynes BF; Johnston M; Kublin J; Lane HC; Pantaleo G; Picker LJ; Fauci AS
Sci Transl Med; 2011 Apr; 3(79):79ps13. PubMed ID: 21508308
[TBL] [Abstract][Full Text] [Related]
13. Tiny steps towards an HIV vaccine.
Willyard C
Nature; 2010 Jul; 466(7304):S8. PubMed ID: 20631706
[No Abstract] [Full Text] [Related]
14. International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China.
Li D; Forrest BD; Li Z; Xue P; Hanson CV; Duan S; Cheng H; Li M; Wang CY; Koff WC
Asian Pac J Allergy Immunol; 1997 Jun; 15(2):105-13. PubMed ID: 9346275
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
Girard MP; Osmanov S; Assossou OM; Kieny MP
Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
[TBL] [Abstract][Full Text] [Related]
16. A global approach to HIV-1 vaccine development.
Stephenson KE; Barouch DH
Immunol Rev; 2013 Jul; 254(1):295-304. PubMed ID: 23772627
[TBL] [Abstract][Full Text] [Related]
17. Support for the RV144 HIV vaccine trial.
AIDS Vaccine Advocacy Coalition
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
[No Abstract] [Full Text] [Related]
18. Progress in HIV vaccine development.
Hsu DC; O'Connell RJ
Hum Vaccin Immunother; 2017 May; 13(5):1018-1030. PubMed ID: 28281871
[TBL] [Abstract][Full Text] [Related]
19. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
20. HIV vaccines in infants and children.
Lambert JS
Paediatr Drugs; 2005; 7(5):267-76. PubMed ID: 16220994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
